Global Peptic Ulcer Drugs Market to Reach $5.3 Billion by 2030
The global market for Peptic Ulcer Drugs estimated at US$4.4 Billion in the year 2022, is projected to reach a revised size of US$5.3 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2022-2030. Antibiotics, one of the segments analyzed in the report, is projected to record 2% CAGR and reach US$2.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Proton Pump Inhibitors (PPIs) segment is readjusted to a revised 2.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 1.9% CAGR
The Peptic Ulcer Drugs market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$927.2 Million by the year 2030 trailing a CAGR of 1.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 1.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.Select Competitors (Total 46 Featured) -
- Abbott Laboratories
- AstraZeneca PLC
- Cadila Healthcare Ltd. (Zydus Cadila)
- Daewoong Pharmaceutical Co., Ltd.
- Eisai Co., Ltd.
- Pharmaking Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Co., Ltd.
- Yuhan Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AstraZeneca PLC
- Cadila Healthcare Ltd. (Zydus Cadila)
- Daewoong Pharmaceutical Co., Ltd.
- Eisai Co., Ltd.
- Pharmaking Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Co., Ltd.
- Yuhan Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 196 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.4 Billion |
Forecasted Market Value ( USD | $ 5.3 Billion |
Compound Annual Growth Rate | 2.4% |
Regions Covered | Global |